NASDAQ · NTRBWHealthcareOrthopedic & Surgical Supplies

Nutriband Inc. Warrant financials

$1.66+26.72%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '27
Jul 31
Q1 '27
Apr 30
Q4 '26
Jan 31
Q3 '26
Oct 31
Q2 '26
Jul 31
Q1 '26
Apr 30
Q4 '25
Jan 31
Q3 '25
Oct 31
Q2 '25
Jul 31
Q1 '25
Apr 30
Q4 '24
Jan 31
Q3 '24
Oct 31
Revenue$437.5K$433.4K$400.7K$346.1K$622.5K$667.4K$642.4K$645.8K$442.8K$408.5K$524.6K$427.8K
Gross profit$181.9K$196.8K$88.9K$68.5K$156.9K$252.0K$285.9K$191.0K$101.6K$164.8K$181.2K$158.9K
Gross margin41.6%45.4%22.2%19.8%25.2%37.8%44.5%29.6%22.9%40.3%34.5%37.1%
Operating income-$890.6K-$1.3M-$1.0M-$3.9M-$2.0M-$1.4M-$5.6M-$1.4M-$1.4M-$1.9M-$1.3M-$1.7M
Net income-$880.6K-$1.2M-$968.1K-$3.9M-$23.8M-$1.4M-$5.5M-$1.4M-$1.7M-$1.9M-$1.9M-$1.8M
Net margin−201.3%−286.6%−241.6%−1119.0%−3825.9%−208.1%−858.8%−211.0%−385.1%−464.6%−358.5%−411.4%
Diluted EPS$-0.07$-0.10$-0.08$-0.32$-2.12$-0.12$-0.50$-0.12$-0.15$-0.17$-0.18$-0.18
EBITDA-$857.3K-$1.2M-$985.0K-$3.8M-$1.9M-$1.4M-$1.9M-$1.4M-$1.3M-$1.8M-$1.2M-$1.7M
Operating cash flow-$585.0K-$563.1K-$731.8K-$1.8M-$1.3M-$1.3M-$1.2M-$1.0M-$1.5M-$833.9K-$718.2K-$1.1M
Free cash flow-$585.0K-$563.1K-$731.8K-$1.8M-$1.3M-$1.3M-$1.2M-$1.1M-$1.6M-$840.1K-$767.4K-$1.1M
Diluted shares12.2M12.2M12.2M12.1M11.2M11.1M11.1M11.1M11.1M11.4M10.4M9.8M

Balance sheet

Period endJul 31Apr 30Jan 31Oct 31Jul 31Apr 30
Cash & equivalents$3.4M$4.0M$4.6M$5.3M$7.0M$3.0M
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$153.5K$159.2K$164.7K$170.2K$175.7K$181.0K
Total assets$6.3M$6.9M$7.5M$8.4M$10.2M$6.2M
Total liabilities$964.4K$902.3K$868.4K$870.2K$1.7M$1.0M
Shareholders' equity$5.3M$6.0M$6.7M$7.5M$8.5M$5.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology